Right to Try for Individualized Treatments Act

This bill changes the federal Right to Try law to cover investigational individualized medical treatments, which are drugs or biological products made for a patient based on that patient's unique genetic profile. Patients diagnosed with a life-threatening disease or condition or a severely debilitating illness could request such a treatment if a physician certifies they have considered approved treatment options and they give written informed consent. A manufacturer operating within a qualifying health care facility may provide the treatment but is not required to. The bill also applies the existing Right to Try exemptions from certain federal drug rules to these individualized treatments.

Full text and official record on Congress.gov

Sponsors

• Diana Harshbarger Republican sponsor
• 3 cosponsors